For the quarter ending 2026-03-31, LGN had $14,454K increase in cash & cash equivalents over the period. $102,290K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income (loss) | 17,394 | -54,674 | -22,629 |
| Amortization of intangible assets | 32,554 | 20,454 | 61,888 |
| Depreciation of property and equipment | 9,722 | 8,223 | 23,723 |
| Goodwill impairment | - | 24,966 | - |
| Long-lived asset impairment | - | 2,415 | - |
| Amortization of debt issuance costs and discounts | 425 | 473 | 3,007 |
| Loss on debt extinguishment | - | -966 | -5,685 |
| Stock-based compensation | 36,652 | 45,669 | 21,881 |
| Changes in fair value of contingent consideration liabilities (including 13,424 for the year ended december31, 2023 from related parties) | - | 0 | - |
| Compensation expense - performance interests | 3,763 | - | - |
| Deferred taxes | -19,321 | 8,909 | 6,378 |
| Tax receivable agreement liability remeasurement | - | -2,914 | - |
| Equity in earnings of joint venture | 504 | 595 | 848 |
| Return on investment in joint venture | - | 1,200 | 500 |
| Operating lease right-of-use asset lease expense | 6,877 | 5,320 | 12,959 |
| Other | -31 | -1,010 | -148 |
| Accounts receivable, net | 59,199 | -9,378 | 139,448 |
| Contract assets | 25,711 | 25,003 | 46,182 |
| Prepaid expenses and other current assets | 1,549 | -1,731 | -1,198 |
| Accounts payable | 26,144 | 23,368 | 94,542 |
| Accrued compensation and benefits | 24,044 | -22,057 | 34,355 |
| Accrued and other current liabilities | -5,856 | -9,857 | -4,110 |
| Contract liabilities | 79,141 | 52,167 | 120,027 |
| Operating lease liabilities, current and long-term | -5,153 | -4,553 | -10,727 |
| Other long-term assets and liabilities | -658 | -2,325 | 223 |
| Cash provided by operating activities | 120,112 | 94,749 | 162,124 |
| Purchases of property and equipment | 17,822 | 13,206 | 24,734 |
| Consideration paid for acquisitions, net of cash acquired | 281,330 | 16,044 | 453 |
| Proceeds from sale of property and equipment | 133 | 164 | 226 |
| Return of investment in joint venture | - | 0 | - |
| Cash used in investing activities | -299,019 | -29,086 | -24,961 |
| Term loan borrowings (including 2,968, 103,500, and 15,000 for the years ended december31, 2025, 2024, and 2023, respectively, from related parties) | - | 2,968 | - |
| Term loan borrowings (including 15,000 and 2,495 in 2026 and 2025, respectively, from related parties) | 200,000 | 57,141 | 2,495 |
| Term loan payments (including 74,797 in 2025 to related parties) | - | 74,797 | - |
| Term loan payments | 2,494 | 57,141 | 795,073 |
| Revolver borrowings | 25,000 | - | - |
| Revolver payments | 25,000 | - | - |
| Notes payable payments | 1,905 | 1,776 | 6,102 |
| Finance lease payments | 1,288 | 1,149 | 2,694 |
| Cash distributions to legence parent | - | 0 | 0 |
| Cash contributions from legence parent | - | 0 | 0 |
| Proceeds from ipo, net of underwriting discounts and commissions | - | 0 | 780,243 |
| Debt issuance costs | 892 | 1,626 | 0 |
| Payments of contingent consideration (including (20,663) and (5,520) for the years ended december31, 2024 and 2023, respectively, from related parties) | - | 0 | 0 |
| Payments for deferred offering costs | 60 | 6,980 | 21,165 |
| Cash provided by (used in) financing activities | 193,361 | -11,531 | -42,296 |
| Increase in cash and cash equivalents | 14,454 | 54,132 | 94,867 |
| Cash and cash equivalents, beginning of period | 230,166 | 176,034 | 81,167 |
| Cash and cash equivalents, end of period | 244,620 | 230,166 | 176,034 |
Legence Corp. (LGN)
Legence Corp. (LGN)